Incidence and risk factors for phaeochromocytoma diagnosis in dogs under primary veterinary care in the UK
PLOS One · 2025
DOI: 10.1371/journal.pone.0332811 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Martin Litviakov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Services, Royal Veterinary College, Hatfield, United Kingdom. Hauptthemen laut MEDLINE: Pheochromocytoma, Dog Diseases, Adrenal Gland Neoplasms. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Veterinary College, Kennel Club Charitable Trust, Agria Pet Insurance.
Abstract (Originalsprache)
Phaeochromocytoma (PCC) is a tumour arising from the adrenal gland in dogs that can be challenging to diagnose. This study aimed to describe the incidence risk, breed predispositions and other demographic risk factors associated with the diagnosis PCC in dogs receiving primary veterinary care in the UK. All anonymised VetCompass Programme electronic health records from dogs receiving primary veterinary care in the UK during 2019 were included. Demographic risk factor analysis used multivariable logistic regression modelling. Out of a study population of 2,250,741 dogs, 92 were confirmed as PCC cases at any time point. The estimated 2019 incidence risk for PCC diagnosis was 1 per 100,000 dogs. The Soft-Coated Wheaten Terrier, German Pointer and Miniature Schnauzer showed significant breed predispositions for the diagnosis of PCC compared with crossbred dogs. Terrier breeds and breeds predisposed to other endocrine tumours were found to have increased odds of being diagnosed with PCC. Furthermore, neutered males and dogs aged between 9 and under 15 years were also associated with increased odds of PCC diagnosis. This study is the first to describe the epidemiology of PCC in dogs receiving primary veterinary care, providing new information concerning demographic risk factors and helping to improve clinical recognition of PCC for veterinary clinicians. Moreover, results from this study facilitate further research in the possible links of canine PCC with other canine endocrine tumours and the existence of concurrent endocrine neoplasia in dogs. Additionally, the results allow researchers to more robustly define useful PCC study populations for future comparative oncology studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Science and Services, Royal Veterinary College, Hatfield, United Kingdom.
- Department of Pathobiology and Population Sciences, Royal Veterinary College, Hatfield, United Kingdom.
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
ORCID-Profile: Martin Litviakov, Dan G O'Neill, Floryne O Buishand
Förderung
- Royal Veterinary College
- Kennel Club Charitable Trust
- Agria Pet Insurance
Zitieren
APA
Litviakov, M., O'Neill, D. G., Brodbelt, D. C., Galac, S., & Buishand, F. O. (2025). Incidence and risk factors for phaeochromocytoma diagnosis in dogs under primary veterinary care in the UK. PLOS One. https://doi.org/10.1371/journal.pone.0332811
Vancouver
Litviakov M, O'Neill DG, Brodbelt DC, Galac S, Buishand FO. Incidence and risk factors for phaeochromocytoma diagnosis in dogs under primary veterinary care in the UK. PLOS One. 2025. doi:10.1371/journal.pone.0332811
BibTeX
@article{Litviakov2025,
author = {Litviakov, Martin and O'Neill, Dan G and Brodbelt, Dave C and Galac, Sara and Buishand, Floryne O},
title = {Incidence and risk factors for phaeochromocytoma diagnosis in dogs under primary veterinary care in the UK},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332811}
}
EUVIMED